School of Medicine


Showing 1-10 of 11 Results

  • Susan Galel

    Susan Galel

    Associate Professor of Pathology at the Stanford University Medical Center, Emerita

    Current Research and Scholarly Interests Transfusion-transmitted infections and donor screening for infectious diseases. National policies for blood banks. Enhancement of transfusion safety and effectiveness, with a focus on quality assurance in blood banking and transfusion therapy; transfusion medicine education; pediatric and adult transfusion therapy.

  • Stephen J. Galli, MD

    Stephen J. Galli, MD

    The Mary Hewitt Loveless, M.D. Professor in the School of Medicine and Professor of Microbiology and Immunology

    Current Research and Scholarly Interests The goals of Dr. Galli's laboratory are to understand the regulation of mast cell and basophil development and the expression of mast cell and basophil function, and to develop and use genetic approaches to elucidate the roles of these cells in health and disease.

  • Sharon Markham Geaghan

    Sharon Markham Geaghan

    Associate Professor of Pathology at the Stanford University Medical Center, Emerita

    Current Research and Scholarly Interests Pediatric Hematopathology, Pediatric Laboratory Medicine and Pathology

  • Bertil Glader

    Bertil Glader

    Professor of Pediatrics (Hematology/Oncology) and, by courtesy, of Pathology

    Current Research and Scholarly Interests Hematology/Oncology, biology, and treatment of bone marrow failure disorders, hereditary coagulation disorders-clinical trials.

  • Lawrence Tim Goodnough

    Lawrence Tim Goodnough

    Professor of Pathology and of Medicine (Hematology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Goodnough has a long-standing interest in alternatives to blood therapy. This includes the concept of antologous blood predonation before elective surgery; acute normovolemic hermodicution;erythropoietic agents to stimulate red blood cell production; pharmacologic strategies to reduce blood loss; artificial oxygen carriers; and re-evaluation of the transfusion trigger. Publications: Goodnough LT: "Erythropoietin", In Scientific Basis of Transfusion Medicine (Anderson K and Ness P),WB Saunders Co, Phila. 1994;830-842. Lenes B, Goodnough LT: Educational aspects of transfusion medicine, In Quality Assurance in Transfusion Medicine: Conceptual, Serologic, and Microbiologic Aspects. (Rock G, Seghatchin MJ, eds.), CRC Press, Boca Raton, FCA, 1992;Ch 5:89-103. Goodnough LT, Geha AS: A new era in blood conservation (editorial). Ann Thor Surg 1991;51:703-704.99.Goodnough LT. Autologous blood donation and transfusion. In Technical Manual (Tyler V, ed) 13th Edition, American Association of Blood Banks, Bethesda, MD, 1999:111-126. Goodnough LT. Alternative strategies in platelet therapy. Transfusion Alternatives in Transfusion Medicine 1999;3:25-30. Goodnough LT. Platelet transfusion therapy. J Clin Apher 2001;16:43-48. Goodnough LT. Red cell support in the perioperative setting. In Rossi's Principles of Transfusion Medicine, 3rd Edition (Simon T, ed), Lippincott, Williams and Wilkins, Philadelphia, PA, 2002; 590-601. Goodnough LT. Book Review "Practical Transfusion Medicine" (Murphy MF, Pamphilon D, eds). Lancet 2001;58:251.145. Goodnough LT. Transfusion Medicine (Reply to Letter). N Engl J Med 2002;347:538-539.148. Goodnough LT. Autologous blood donation and transfusion. In Technical Manual (Brecher M, ed), 14th Edition, American Association of Blood Banks, Bethesda, MD, 2002; pp 105-126.149.Goodnough LT. Platelet and granulocyte antigens and antibodies. In Technical Manual (Brecher M, ed), 14th Edition, American Association of Blood Banks, Bethesda, MD, 2002; pp 341-360.171. Goodnough LT. Blood and blood conservation: A national perspective. 2003; J Cardiothor Vasc Anesth 2004; 18(5)65-115.

  • Isabella Graef

    Isabella Graef

    Assistant Professor of Pathology

    Current Research and Scholarly Interests We are interested in addressing questions in neuronal development and function by a combination of genetic, cell biological, biochemical and chemical approaches.
    The main focus of our lab is centered around two topics: 1) the interface of signaling and gene regulation in neuronal development, with a focus on calcineurin-NFAT signaling; 2) the development of small molecules, which interfere with protein-protein interactions underlying neurodegenerative diseases.

  • Dita Gratzinger

    Dita Gratzinger

    Assistant Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests I have research interests in the interaction of hematolymphoid neoplasia with the microenvironment. For example, I use a combination of immunohistochemistry, immunofluorescence and image analysis techniques to evaluate the mesenchymal stromal cell compartment in myelodysplastic syndrome (pre-leukemic bone marrow failure disorder). I also have interests in lymphoma vasculature and the tropism of lymphoma for specific types of vasculature.

Stanford Medicine Resources: